美国 · 平台与数据 · TipRanks

Luye Pharma’s Ruoxinlin Renewed in China’s 2026 Reimbursement Drug List

来源：TipRanks · 美国 17 小时前

详细摘要

Luye Pharma Group ( ($HK:2186) ) has shared an update. Ruoxinlin, approved in China in November 2022 and first included in the reimbursement list in November 2024, ...

在 TipRanks 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.tipranks.com)

Luye Pharma’s Ruoxinlin Renewed in China’s 2026 Reimbursement Drug List

详细摘要

推荐阅读

Insider Buying: Hudson Pacific Properties (NYSE:HPP) President Purchases $43,650.00 in Stock

3 Magnificent Stocks to Buy Before 2027 and Hold for a Decade

'Scrooge' collects $19M, finds weekend receipts surprisingly festive

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Prediction: When Will Bitcoin Get Back to Its All-Time High?

Veteran trader warns Bitcoin's record may outlive him

Luye Pharma’s Ruoxinlin Renewed in China’s 2026 Reimbursement Drug List

详细摘要

分享

推荐阅读

Insider Buying: Hudson Pacific Properties (NYSE:HPP) President Purchases $43,650.00 in Stock

3 Magnificent Stocks to Buy Before 2027 and Hold for a Decade

'Scrooge' collects $19M, finds weekend receipts surprisingly festive

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Prediction: When Will Bitcoin Get Back to Its All-Time High?

Veteran trader warns Bitcoin's record may outlive him